1.
LAXMI SANKALPA BHAGANAGARAPU, SARUMATHY SUNDARARAJAN. NOVEL APPROACHES FOR ANEMIA IN CARDIORENAL SYNDROME: A RANDOMIZED CONTROLLED TRIAL OF HYPOXIA-INDUCIBLE FACTOR PROLYL HYDROXYLASE INHIBITOR VS SGLT2 INHIBITOR. Asian J Pharm Clin Res [Internet]. 2025 Dec. 7 [cited 2025 Dec. 14];18(12):184-91. Available from: https://www.journals.innovareacademics.in/index.php/ajpcr/article/view/57009